European Hemostats & Sealants Market by Brand (Hemopatch [Baxter], Tachosil [Takeda], Veriset [Medtronic], Avitene [C.R Bard], Sangustop [B Braun], Lyostypt [B Braun]), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024
“European Hemostats and Sealants market to register a CAGR of 7.0% from 2019 to 2024”
The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0% during the forecast period. Growth in this market is mainly driven by the increasing number of surgical procedures and the favorable reimbursement scenario in the European region.
“Tachosil exhibited the highest CAGR over the forecast period.”
By brand, the hemostats and sealants market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Over the forecast period, Tachosil accounted for the highest CAGR. The product provides effective results in emergency cases.
“Germany exhibited the largest share in the market”
Germany accounted for the largest share in the hemostats and sealants market. The large share of this market segment can be attributed to the larger patient population and surgical procedures.
Breakdown of supply-side primary interviews, by type, designation, and country:
This report studies the European hemostats and sealants market based on brand and countries. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total hemostats and sealants market. The report forecasts the revenue of the brands with respect to five major countries.
Reasons to Buy the Report:
The report provides insights on the following pointers:
The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0% during the forecast period. Growth in this market is mainly driven by the increasing number of surgical procedures and the favorable reimbursement scenario in the European region.
“Tachosil exhibited the highest CAGR over the forecast period.”
By brand, the hemostats and sealants market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Over the forecast period, Tachosil accounted for the highest CAGR. The product provides effective results in emergency cases.
“Germany exhibited the largest share in the market”
Germany accounted for the largest share in the hemostats and sealants market. The large share of this market segment can be attributed to the larger patient population and surgical procedures.
Breakdown of supply-side primary interviews, by type, designation, and country:
- By Respondent Type: Supply (79%) and Demand (21%)
- By Designation: Manufacturer (81%) and Distributor (19%)
- By Country: Germany (25%), UK (21%), France (21%), Italy (18%), and Spain (15%)
This report studies the European hemostats and sealants market based on brand and countries. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total hemostats and sealants market. The report forecasts the revenue of the brands with respect to five major countries.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the hemostats and sealants offered by the top players in the hemostats and sealants market. The report analyzes the hemostats and sealants market by brand and country.
- Market Development: Comprehensive information about the lucrative markets. The report analyzes the markets for focused hemostats and sealants across the EU5.
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKETS COVERED
1.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 ASSUMPTIONS & LIMITATIONS
2. RESEARCH METHODOLOGY
2.1 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2 FORECAST MODEL STEPS
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1 RESPONDENT PROFILE
4.2 INTRODUCTION
4.3 MARKET DYNAMICS
4.4 SEALING PRODUCTS
5. HEMOSTATS MARKET, BY PRODUCT & COUNTRY
5.1 SANGUSTOP
5.1.1 GERMANY
5.1.2 UK
5.1.3 FRANCE
5.1.4 ITALY
5.1.5 SPAIN
5.2 LYOSTYPT
5.2.1 GERMANY
5.2.2 UK
5.2.3 FRANCE
5.2.4 ITALY
5.2.5 SPAIN
5.3 AVITENE
5.3.1 GERMANY
5.3.2 UK
5.3.3 FRANCE
5.3.4 ITALY
5.3.5 SPAIN
5.4 TACHOSIL
5.4.1 GERMANY
5.4.2 UK
5.1.3 FRANCE
5.4.4 ITALY
5.4.5 SPAIN
5.5 HEMOPATCH
5.5.1 GERMANY
5.5.2 UK
5.5.3 FRANCE
5.5.4 ITALY
5.5.5 SPAIN
5.6 VERISET
5.6.1 GERMANY
5.6.2 UK
5.6.3 FRANCE
5.6.4 ITALY
5.6.5 SPAIN
6. APPENDIX
1.1 OBJECTIVES OF THE STUDY
1.2 MARKETS COVERED
1.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 ASSUMPTIONS & LIMITATIONS
2. RESEARCH METHODOLOGY
2.1 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2 FORECAST MODEL STEPS
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1 RESPONDENT PROFILE
4.2 INTRODUCTION
4.3 MARKET DYNAMICS
4.4 SEALING PRODUCTS
5. HEMOSTATS MARKET, BY PRODUCT & COUNTRY
5.1 SANGUSTOP
5.1.1 GERMANY
5.1.2 UK
5.1.3 FRANCE
5.1.4 ITALY
5.1.5 SPAIN
5.2 LYOSTYPT
5.2.1 GERMANY
5.2.2 UK
5.2.3 FRANCE
5.2.4 ITALY
5.2.5 SPAIN
5.3 AVITENE
5.3.1 GERMANY
5.3.2 UK
5.3.3 FRANCE
5.3.4 ITALY
5.3.5 SPAIN
5.4 TACHOSIL
5.4.1 GERMANY
5.4.2 UK
5.1.3 FRANCE
5.4.4 ITALY
5.4.5 SPAIN
5.5 HEMOPATCH
5.5.1 GERMANY
5.5.2 UK
5.5.3 FRANCE
5.5.4 ITALY
5.5.5 SPAIN
5.6 VERISET
5.6.1 GERMANY
5.6.2 UK
5.6.3 FRANCE
5.6.4 ITALY
5.6.5 SPAIN
6. APPENDIX
LIST OF TABLES
TABLE 1 EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY BRAND, 2017 - 2024
TABLE 2 EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 3 SANGUSTOP MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 4 LYOSTYPT MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 5 AVITENE MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 6 TACHOSIL MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 7 HEMOPATCH MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 8 VERISET MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 1 EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY BRAND, 2017 - 2024
TABLE 2 EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 3 SANGUSTOP MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 4 LYOSTYPT MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 5 AVITENE MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 6 TACHOSIL MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 7 HEMOPATCH MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
TABLE 8 VERISET MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
LIST OF FIGURES
FIGURE 1 BRAND MARKET, COUNTRY
FIGURE 2 COUNTRY PRESENCE
FIGURE 3 NUMBER OF RESPONDENTS, BY TYPE
FIGURE 4 NUMBER OF RESPONDENTS, BY COUNTRY
FIGURE 5 SUPPLY SIDE RESPONDENTS, BY TYPE
FIGURE 6 DEMAND SIDE RESPONDENTS, BY DESIGNATION
FIGURE 1 BRAND MARKET, COUNTRY
FIGURE 2 COUNTRY PRESENCE
FIGURE 3 NUMBER OF RESPONDENTS, BY TYPE
FIGURE 4 NUMBER OF RESPONDENTS, BY COUNTRY
FIGURE 5 SUPPLY SIDE RESPONDENTS, BY TYPE
FIGURE 6 DEMAND SIDE RESPONDENTS, BY DESIGNATION
